1 Kozower BD, Larner JM, Detterbeck FC, Jones DR. Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143: e369S–99S.
2 Ettinger DS, Wood DE, Akerley W et al. NCCN guidelines insights: Non-small cell lung cancer, version 4.2016. J Natl Compr Canc Netw 2016; 14: 255–64.
3 Howington J, Blum M, Chang A, Balekian A, Murthy S. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd edition. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143: 278–313.
4 Bendixen M, Jørgensen OD, Kronborg C, Andersen C, Licht PB. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: A randomised controlled trial. Lancet Oncol 2016; 17: 836–44.
5 Agostini P, Cieslik H, Rathinam S et al. Postoperative pulmonary complications following thoracic surgery: Are there any modifiable risk factors? Thorax 2010; 65: 815–8.
6 Mazo V, Sabaté S, Canet J et al. Prospective external validation of a predictive score for postoperative pulmonary complications. Anesthesiology 2014; 121: 219–31.
7 Canet J, Gallart L. Predicting postoperative pulmonary complications in the general population. Curr Opin Anaesthesiol 2013; 26: 107–15.
8 Allen MS, Darling GE, Pechet TT et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: Initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006; 81: 1013–20.
9 Boffa DJ, Allen MS, Grab JD, Gaissert HA, Harpole DH, Wright CD. Data from the society of thoracic surgeons general thoracic surgery database: The surgical management of primary lung tumors. J Thorac Cardiovasc Surg 2008; 135: 247–54.
10 Rueth NM, Andrade RS. Is VATS lobectomy better: Perioperatively, biologically and oncologically? Ann Thorac Surg 2010; 89: 2107–11.
11 Smetana GW, Lawrence VA, Cornell JE. Preoperative pulmonary risk stratification for noncardiothoracic surgery: Systematic review for the American College of Physicians. Ann Intern Med 2006; 144: 581–95.
12 Canet J, Mazo V. Postoperative pulmonary complications. Minerva Anestesiol 2010; 76: 138–43.
13 Lugg ST, Agostini PJ, Tikka T et al. Long-term impact of developing a postoperative pulmonary complication after lung surgery. Thorax 2016; 71: 171–6.
14 Wang S, Li X, Li Y et al. The long-term impact of postoperative pulmonary complications after video-assisted thoracic surgery lobectomy for lung cancer. J Thorac Dis 2017; 9: 5143–52.
15 Yang Y, Gao P, Song Y et al. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta- analysis. Eur J Surg Oncol 2016; 42: 1176–82.
16 Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 world health organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol 2015; 10: 1240–2.
17 Goldstraw P, Chansky K, Crowley J et al. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2016; 11: 39–51.
18 Hamaguchi Y, Kaido T, Okumura S et al. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition 2016; 32: 1200–5.
19 Nakamura R, Inage Y, Tobita R et al. Sarcopenia in resected NSCLC: Effect on postoperative outcomes. J Thorac Oncol 2018; 13: 895–903.
20 McKenna RJ Jr. Complications and learning curves for video-assisted thoracic surgery lobectomy. Thorac Surg Clin 2008; 18: 275–80.
21 Samson P, Guitron J, Reed MF, Hanseman DJ, Starnes SL. Predictors of conversion to thoracotomy for video-assisted thoracoscopic lobectomy: A retrospective analysis and the influence of computed tomography-based calcification assessment. J Thorac Cardiovasc Surg 2013; 145: 1512–8.
22 Villamizar NR, Darrabie M, Hanna J et al. Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung cancer. J Thorac Cardiovasc Surg 2013; 145: 514–20.
23 Bongiolatti S, Gonfiotti A, Viggiano D et al. Risk factors and impact of conversion from VATS to open lobectomy: Analysis from a national database. Surg Endosc 2019. [Epub ahead of print]. https://doi.org/10.1007/s00464-019-06682-5.
24 Birim O, Kappetein AP, Waleboer M et al. Long-term survival after non-small cell lung cancer surgery: Development and validation of a prognostic model with a preoperative and postoperative mode. J Thorac Cardiovasc Surg 2006; 132: 491–8.
25 Birim O, Kappetein AP, Bogers AJ. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg 2005; 28: 759–62.
26 Mery CM, Pappas AN, Bueno R et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005; 128: 237–45.
27 Berry MF, Hanna J, Tong BC et al. Risk factors for morbidity after lobectomy for lung cancer in elderly patients. Ann Thorac Surg 2009; 88: 1093–109.
28 Rueth NM, Parsons HM, Habermann EB et al. Surgical treatment of lung cancer: Predicting postoperativemorbidity in the elderly population. J Thorac Cardiovasc Surg 2012; 143: 1314–23.
29 Zhang R, Kyriss T, Dippon J, Ciupa S, Boedeker E, Friedel G. Impact of comorbidity burden on morbidity following thoracoscopic lobectomy: A propensity-matched analysis. J Thorac Dis 2018; 10: 1806–14.
30 Kouritas VK, Kefaloyannis E, Tcherveniakov P et al. Do pleural adhesions influence the outcome of patients undergoing major lung resection? Interact Cardiovasc Thorac Surg 2017; 25: 613–9.
31 Augustin F, Maier HT, Weissenbacher A et al. Causes, predictors and consequences of conversion from VATS to open lung lobectomy. Surg Endosc 2016; 30: 2415–21.
32 Li SJ, Zhou K, Wu YM et al. Presence of pleural adhesions can predict conversion to thoracotomy and postoperative surgical complications in patients undergoing video-assisted thoracoscopic lung cancer lobectomy. J Thorac Dis 2018; 10: 416–31.
33 Fan H, Shao ZY, Xiao YY et al. Comparison of the Glasgow prognostic score (GPS) and the modified Glasgow prognostic score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer. J Cancer Res Clin Oncol 2016; 142: 1285–97.
34 Rivadeneira DE, Grobmyer SR, Naama HA et al. Malnutrition-induced macrophage apoptosis. Surgery 2001; 129: 617–25.
35 Sun C, Anraku M, Karasaki T et al. Low truncal muscle area on chest computed tomography: A poor prognostic factor for the cure of early-stage non-small-cell lung cancer. Eur J Cardiothorac Surg 2019; 55: 414–20. https://doi.org/10.1093/ ejcts/ezy324.
36 Kim EY, Kim YS, Park I, Ahn HK, Cho EK, Jeong YM. Prognostic significance of CT-determined sarcopenia in patients with small-cell lung cancer. J Thorac Oncol 2015; 10: 1795–9.
37 Kilgour RD, Vigano A, Trutschnigg B et al. Cancer-related fatigue: The impact of skeletal muscle mass and strength in patients with advanced cancer. J Cachexia Sarcopenia Muscle 2010; 1: 177–85.
38 Kim CR, Kim EY, Kim YS et al. Histologic subtypes are not associated with the presence of sarcopenia in lung cancer. PLOS One 2018; 13: e0194626. https://doi.org/10.1371/journal.pone.0194626.
39 Collins J, Noble S, Chester J, Coles B, Byrne A. The assessment and impact of sarcopenia in lung cancer: A systematic literature review. BMJ Open 2014; 4: e003697. https://doi.org/10.1136/bmjopen-2013-003697.
40 Tsukioka T, Nishiyama N, Izumi N et al. Sarcopenia is a novel poor prognostic factor in male patients with pathological stage I non-small cell lung cancer. Jpn J Clin Oncol 2017; 47: 363–8.
41 Miller JA, Harris K, Roche C et al. Sarcopenia is a predictor of outcomes after lobectomy. J Thorac Dis 2018; 10: 432–40.
論文の公開元へ
